Butyrate regulates the expression of pathogen-triggered IL-8 in intestinal epithelia

Pediatr Res. 2007 Nov;62(5):542-6. doi: 10.1203/PDR.0b013e318155a422.

Abstract

Inflammatory bowel disease (IBD) is characterized by an exaggerated immune response that involves pro-inflammatory cytokines including IL-8. Production of these pro-inflammatory cytokines is triggered by pathogen-associated molecular patterns (PAMP). Butyrate, a product of bacterial fermentation of carbohydrates, has been reported to modulate inflammation in IBD, possibly by regulating production of pro-inflammatory cytokines. However, this effect of butyrate is controversial. In this study, we used Pam3CSK4 (Pam3CysSerLys4), the acylated NH2-terminus of the bacterial lipoprotein (a PAMP), to mimic in vivo infection of pathogens. Butyrate transiently down-regulated expression of IL-8 stimulated by Pam3CSK4. Treatment of cells with butyrate before Pam3CSK4, however, enhanced production of IL-8. Furthermore, butyrate induced expression of A20, a negative regulator of the nuclear factor-kappaB pathway. Over-expression of A20 inhibited Pam3CSK4-triggered IL-8 expression. Our data suggest that the inflammatory modulation of butyrate in IBD is mediated by A20 and a short pulse rather than continuous administration of butyrate may provide a protective effect on IBD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / pharmacology*
  • Anti-Inflammatory Agents / therapeutic use
  • Butyrates / pharmacology*
  • Butyrates / therapeutic use
  • Caco-2 Cells
  • DNA-Binding Proteins
  • Dose-Response Relationship, Drug
  • Gastrointestinal Agents / pharmacology*
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • I-kappa B Proteins / metabolism
  • Inflammatory Bowel Diseases / drug therapy
  • Inflammatory Bowel Diseases / metabolism
  • Interleukin-8 / metabolism*
  • Intestinal Mucosa / drug effects*
  • Intestinal Mucosa / metabolism
  • Intestines / drug effects*
  • Intestines / embryology
  • Intracellular Signaling Peptides and Proteins / genetics
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Lipopeptides
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / metabolism
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Organ Culture Techniques
  • Peptides / metabolism*
  • Phosphorylation
  • Time Factors
  • Transfection
  • Tumor Necrosis Factor alpha-Induced Protein 3

Substances

  • Anti-Inflammatory Agents
  • Butyrates
  • DNA-Binding Proteins
  • Gastrointestinal Agents
  • I-kappa B Proteins
  • Interleukin-8
  • Intracellular Signaling Peptides and Proteins
  • Lipopeptides
  • NF-kappa B
  • NFKBIA protein, human
  • Nuclear Proteins
  • Pam(3)CSK(4) peptide
  • Peptides
  • NF-KappaB Inhibitor alpha
  • TNFAIP3 protein, human
  • Tumor Necrosis Factor alpha-Induced Protein 3